ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

IKT Inhibikase Therapeutics Inc

1.39
0.05 (3.73%)
May 03 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Inhibikase Therapeutics Inc IKT NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.05 3.73% 1.39 23:00:10
Open Price Low Price High Price Close Price Previous Close
1.38 1.3304 1.51 1.39 1.34
more quote information »

Recent News

Date Time Source Heading
4/18/202415:30GLOBEInhibikase Therapeutics Issues Letter to Shareholders and..
4/03/202407:05GLOBEInhibikase Therapeutics Announces Pre-IND Meeting with the..
3/27/202415:15GLOBEInhibikase Therapeutics Reports Fourth Quarter and Full Year..
3/07/202407:30GLOBEInhibikase Therapeutics to Provide Trial Update for..
2/28/202415:05GLOBEInhibikase Therapeutics Announces Full Outcomes of its..
2/07/202406:59EDGAR2Form 8-K - Current report
2/07/202406:55GLOBEInhibikase Therapeutics Announces Preliminary Outcomes of..
2/01/202415:49EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2/01/202415:09EDGAR2Form 8-K - Current report
1/29/202408:05GLOBEInhibikase Therapeutics Announces Publication Highlighting..
1/16/202415:31EDGAR2Form 8-K - Current report
1/16/202415:05GLOBEInhibikase Therapeutics Announces Planned Retirement of..
12/19/202307:30GLOBEInhibikase Therapeutics Issues Letter to Shareholders and..
12/04/202307:35GLOBEInhibikase Therapeutics Granted Pre-NDA Meeting with the FDA..
11/14/202315:30GLOBEInhibikase Therapeutics Reports Third Quarter Financial..
11/07/202308:28GLOBECorrecting & Replacing -- Inhibikase Therapeutics to Report..
11/07/202307:00GLOBEInhibikase Therapeutics to Report Second Quarter Financial..
10/16/202316:24EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
10/16/202306:00GLOBEInhibikase Therapeutics Highlights Unblinded Functional..
10/04/202307:30GLOBEInhibikase Therapeutics Receives FDA Orphan Drug Designation..
9/20/202310:23EDGAR2Form 8-K - Current report
8/24/202307:30PRNUSInhibikase Therapeutics Announces Development of Novel..
8/22/202307:05PRNUSInhibikase Therapeutics to Present at the International..
8/21/202307:30PRNUSInhibikase Therapeutics Initiates Development of Second..
8/17/202307:30PRNUSInhibikase Therapeutics Announces Completion of the 501..
8/14/202315:20PRNUSInhibikase Therapeutics Reports Second Quarter Financial..
8/14/202315:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/07/202307:05PRNUSInhibikase Therapeutics to Report Second Quarter Financial..
7/17/202316:29EDGAR2Form 8-K - Current report
7/17/202315:05PRNUSInhibikase Therapeutics Regains Compliance with Nasdaq..
7/05/202320:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/05/202320:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/29/202311:15EDGAR2Form 8-K - Current report
6/29/202308:29PRNUSInhibikase Therapeutics Announces a 1-for-6 Reverse Stock..
6/22/202307:05PRNUSInhibikase Therapeutics Announces Selection of the..
6/21/202307:05PRNUSInhibikase Therapeutics Initiates Medical and Patient..
5/30/202307:05PRNUSInhibikase Therapeutics to Present at the LD Micro..
5/16/202306:45PRNUSInhibikase Therapeutics Announces Dosing of First Patient in..
5/15/202307:30PRNUSInhibikase Therapeutics Reports First Quarter Financial..
5/08/202307:05PRNUSInhibikase Therapeutics to Report First Quarter Financial..

Your Recent History

Delayed Upgrade Clock